← Eichor
Condition: Schizophrenia 1 Disorder Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Schizophrenia 1 Disorder

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

PS-Trauma - Development of Trauma Treatment for Patients With Co-morbid Psychotic Disorders and Traumas
NA · 1 location(s) · Nikolai Albert · NCT07242586Single and Multiple Ascending Doses of NTX-253 in Healthy Participants and Participants With Stable Schizophrenia
EARLY_Phase 1 · 1 location(s) · Neurosterix · NCT07344948Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 1)
NA · 1 location(s) · The University of Texas Health Science Center, Houston · NCT06345963A Phase 1 MAD Study to Evaluate the Safety and Tolerability of LY03020
Phase 1 · 1 location(s) · Luye Pharma Group Ltd. · NCT07230652Non-invasive Brain Stimulation Using Tdcs of the Third (of Many) Visual Pathways
NA · 1 location(s) · Nathan Kline Institute for Psychiatric Research · NCT07469384Multi-target TMS for Schizophrenia Negative Symptoms
NA · 1 location(s) · Shanghai Mental Health Center · NCT07559084TOPUS - Testing an Implemented Intervention to Reduce Duration of Untreated Psychosis
Phase N/A · 2 location(s) · Mental Health Centre Copenhagen, Bispebjerg and Frederiksber · NCT07716969The Effects of a Solution-Focused Approach on Psychosocial Adjustment and Treatment Compliance in Individuals Diagnosed
NA · 1 location(s) · Muş Alparslan University · NCT07144592Exercise-based Program for Rehabilitation of Veterans With Severe Mental Illness
NA · 1 location(s) · VA Office of Research and Development · NCT05157620A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT
Phase 1 · 8 location(s) · Bristol-Myers Squibb · NCT07061288Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
Phase N/A · 6 location(s) · Beth Israel Deaconess Medical Center · NCT06740383Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder
Phase 4 · 1 location(s) · Mayo Clinic · NCT07213466Digital Strategies to Advance Help-Seeking Aim 1 and 2
Phase N/A · 1 location(s) · Columbia University · NCT06774430Cognitive Strategies in Early Psychosis 1
Phase 3 · 1 location(s) · University of Minnesota · NCT07231497Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
Phase 4 · 9 location(s) · Vanda Pharmaceuticals · NCT05648591CLOZAPINE Response in Biotype-1
Phase 4 · 5 location(s) · University of Texas Southwestern Medical Center · NCT04580134A PET/MRI Study of Cobenfy on Dopamine Transmission in Schizophrenia
Phase 1/Phase 2 · 1 location(s) · New York State Psychiatric Institute · NCT07423546Effects of Tirzepatide on Alcohol Intake in Patients Diagnosed With Schizophrenia and Alcohol Use Disorder
Phase 2 · 2 location(s) · Anders Fink-Jensen, MD, DMSci · NCT06939088
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.